W. Cliff Rutter
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Antimicrobial Resistance in Staphylococcus 6
- Co-authors
- David S. Burgess (19 shared papers)Donna R. Burgess (10 shared papers)Craig A. Martin (6 shared papers)Jeffery Talbert (1 shared paper)Ryan L. Crass (1 shared paper)Ronald G. Hall (1 shared paper)Grace C. Lee (1 shared paper)David J. Feola (1 shared paper)
- Journals
- Open Forum Infectious Diseases (10 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Cystic Fibrosis (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)Annals of Surgery (1 paper)
- Partner nations
- United States
In The Last Decade
W. Cliff Rutter
21 papers receiving 401 citations
Peers
Comparison fields: 5 of 54
- Molecular Medicine 78
- Pharmacology 166
- Nephrology 59
- Applied Microbiology and Biotechnology 15
- Infectious Diseases 87
Countries citing papers authored by W. Cliff Rutter
This map shows the geographic impact of W. Cliff Rutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Cliff Rutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Cliff Rutter more than expected).
Fields of papers citing papers by W. Cliff Rutter
This network shows the impact of papers produced by W. Cliff Rutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Cliff Rutter. The network helps show where W. Cliff Rutter may publish in the future.
Co-authors
The 25 scholars most cited alongside W. Cliff Rutter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 94 | |
| 2 | 2017 | 54 | |
| 3 | 2018 | 51 | |
| 4 | 2016 | 48 | |
| 5 | 2017 | 34 | |
| 6 | 2017 | 29 | |
| 7 | 2017 | 21 | |
| 8 | 2018 | 20 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 11 | |
| 11 | 2016 | 11 | |
| 12 | 1974 | 6 | |
| 13 | 2016 | 3 | |
| 14 | 2022 | 2 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2015 | 1 |
About W. Cliff Rutter
W. Cliff Rutter is a scholar working on Pharmacology, Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Medicine and Nephrology, having authored 24 papers that have together received 407 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Cystic Fibrosis Research Advances (4 papers), Antibiotic Resistance in Bacteria (4 papers), Acute Kidney Injury Research (3 papers), Opioid Use Disorder Treatment (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Molecular Medicine (78 citations), Pharmacology (166 citations), Nephrology (59 citations), Applied Microbiology and Biotechnology (15 citations) and Infectious Diseases (87 citations). W. Cliff Rutter has collaborated with scholars based in United States. Frequent co-authors include David S. Burgess, Donna R. Burgess, Craig A. Martin, Jeffery Talbert, Ryan L. Crass, Ronald G. Hall, Grace C. Lee, David J. Feola, Ying Suo and Kaye H. Kilburn. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Cystic Fibrosis, Diagnostic Microbiology and Infectious Disease and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.